Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News

    Latest News - Page 232

    Pharma sector may give 25 percent returns in pre-election year: Report

    Pharma sector may give 25 percent returns in pre-election year: Report

    Ruby Khatun Khatun3 Sept 2018 10:00 AM IST
    New Delhi: The healthcare sector has long been the underperformer but is likely to give as much as 25 percent returns in the pre-election year, while...
    FDA approves two new HIV drugs from Merck

    FDA approves two new HIV drugs from Merck

    Ruby Khatun Khatun3 Sept 2018 9:30 AM IST
    Merck & Co Inc said the U.S. Food And Drug Administration approved two of its HIV oral drugs, nearly two months ahead of schedule.The drugs have...
    Cadila Healthcare subsidiary gets 5 observations from USFDA

    Cadila Healthcare subsidiary gets 5 observations from USFDA

    Ruby Khatun Khatun2 Sept 2018 10:45 AM IST
    Mumbai: Pharma Major Cadila Healthcare said that USFDA inspected the injectables manufacturing facility of Liva Pharmaceuticals Ltd a 100 percent...
    Suven Life Sciences secures Product Patents in China, Eurasia

    Suven Life Sciences secures Product Patents in China, Eurasia

    Ruby Khatun Khatun2 Sept 2018 10:30 AM IST
    Mumbai: Pharma Major, Suven Life Sciences Ltd announced the grant of one product patent from China and one product patent from Eurasia corresponding...
    FDA recalls Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles

    FDA recalls Montelukast tablets by Camber Pharmaceuticals due to incorrect drug in bottles

    Ruby Khatun Khatun2 Sept 2018 10:00 AM IST
    The U.S. Food and Drug Administration (FDA) is warning consumers and healthcare professionals about a voluntary recall of one lot of Montelukast...
    HCA Healthcare to buy Mission Health for 1.5 billion dollar

    HCA Healthcare to buy Mission Health for 1.5 billion dollar

    Ruby Khatun Khatun2 Sept 2018 9:45 AM IST
    HCA Healthcare Inc, the biggest hospital operator in the United States, said on Friday it would buy Mission Health, a non-profit health system in...
    Chinas Fosun Pharma stock tumbles after regulators spot check on subsidiary

    China's Fosun Pharma stock tumbles after regulator's spot check on subsidiary

    Ruby Khatun Khatun2 Sept 2018 9:30 AM IST
    SHANGHAI: Shanghai Fosun Pharmaceutical Group Co Ltd saw its shares tumble by as much as 10 percent on Friday after it said regulators had made an...
    Ban on Oxytocin manufacture, sale: Delhi High Court suspends ban till October 1

    Ban on Oxytocin manufacture, sale: Delhi High Court suspends ban till October 1

    Ruby Khatun Khatun1 Sept 2018 1:44 PM IST
    The ban on the production and sale of the Oxytocin formulation has been suspended by the Delhi High Court till October 1st, 2018.New Delhi: The Delhi...
    Lupin gets USFDA approval for generic Potassium Chloride Oral Solution

    Lupin gets USFDA approval for generic Potassium Chloride Oral Solution

    Ruby Khatun Khatun1 Sept 2018 11:00 AM IST
    The company's product is a generic version of Genus Lifesciences Inc's Potassium chloride oral solution in the same strengthsNew Delhi: Drug firm...
    Sun Pharma launches Volini Maxx with Virat Kohli as brand ambassador

    Sun Pharma launches Volini Maxx with Virat Kohli as brand ambassador

    Ruby Khatun Khatun1 Sept 2018 10:00 AM IST
    Mumbai: Sun Pharma Consumer Healthcare, a division of Sun Pharmaceutical Industries Ltd announced the launch of Volini Maxx, India’s strongest pain...
    Medical device maker Stryker to buy K2M Group for about 1.4 billion

    Medical device maker Stryker to buy K2M Group for about 1.4 billion

    Ruby Khatun Khatun1 Sept 2018 9:47 AM IST
    Medical device maker Stryker Corp said it will buy smaller rival K2M Group Holdings Inc for about $1.4 billion, adding K2M's fast-growing spinal...
    AstraZenecas experimental lupus drug fails to meet main goal in study

    AstraZeneca's experimental lupus drug fails to meet main goal in study

    Ruby Khatun Khatun1 Sept 2018 9:30 AM IST
    AstraZeneca’s experimental drug anifrolumab failed to meet its main target in a late-stage clinical study treating patients with moderate to severe...
    PrevNext

    Popular Stories

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Owners of BLK Hospital, Nanavati Hospital now own 49.7 percent stake in Max Healthcare

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Hydroxychloroquine not approved as anti-malarial drug in India, says Ipca Laboratories Joint MD

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes feedback

    Union Pharma Secretary Holds video conference with Pharma manufacturers and associations, takes...

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    Owner of BLK Hospital, Radiant Life care looks to buy Max Healthcare stake

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok